![]() |
![]() |
Our CliniciansChristina J. Kim, MD Assistant Professor, Department of Surgery, Section of Surgical Oncology
EDUCATION Medical School: Pritzker School of Medicine, University of Chicago, Chicago, IL Fellowship: Surgical Oncology, H. Lee Moffitt Cancer Center, Tampa, FL PROFESSIONAL EXPERIENCE The University of Arizona, Tucson, AZ SELECTED PUBLICATIONSKim CJ , Yeatman T, Barthel JS, Trotti A, Dinwoodie W, Karl RC, Marcet J. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg. 2001;234(3):352-359. Kim CJ , Puleo C, Letson GD, Reintgen DS. Hyperthermic isolated limb perfusion for extremity sarcoma. Cancer Control. 2001;8(3):269-273. Kim CJ , Reintgen DS, Yeatman TJ. AJCC Melanoma Staging Committee. The promise of microarray technology in melanoma care. Cancer Control. 2002;9(1):49-53. Kim CJ , Reintgen DS, Balch CM. The new melanoma staging system. Cancer Control. 2002;9(1):9-15. Kim CJ , Dessureault S, Gabrilovich D, Reintgen DS, Slingluff C. Immunotherapy for melanoma. Cancer Control. 2002;9(1):22-30. O’Day S, Kim CJ, Reintgen DS. Metastatic melanoma: chemotherapy to biochemotherapy. Cancer Control. 2002;9(1):31-38. Kim CJ , Cox C, Dupont E, Reintgen DS. Accurate staging of women with breast cancer [editorial]. J Surg Oncol. 2002;79(1):2-4. McKee MD, Cecco SA, Niemela JE, Cormier J, Kim CJ, Steinberg SM, Rehak NN, Elin, RJ, Rosenberg SA. Effects of IL-2 therapy on lymphocyte magnesium levels. J Lab Clin Med. 2002;139(1):5-12. Futscher BW, O’Meara M, Kim CJ, Rennels M, Lu D, Gruman L, Seftor R, Hendrix M, Domann F. Aberrant methylation of the maspin promoter is an early event in human breast cancer. Neoplasia. 2004;6(4):380-9. |
||
Division of Women's Cancers
|
||
All contents ©2005 Arizona Board of Regents.
All rights reserved.
|
||